Implantable Micro-Biosensor and Method for Operating the Same
Summary
USPTO granted patent US12599318B2 to Bionime Corporation on April 14, 2026, for an implantable micro-biosensor device. The invention includes a substrate with multiple working electrodes and a counter electrode configured to measure physiological signals and consume interfering substances. The patent contains 11 claims covering the biosensor architecture and operating method.
What changed
USPTO granted patent US12599318B2 to Bionime Corporation for an implantable micro-biosensor system. The patent covers a device with a first working electrode for measuring physiological signals, a second working electrode for consuming interfering substances, and a counter electrode for regeneration of silver halide. The filing date was August 3, 2020, with application number 16983148.
Medical device manufacturers developing continuous glucose monitoring or other implantable biosensor technologies should conduct freedom-to-operate analyses to assess potential patent infringement risks. The 11 granted claims establish enforceable IP rights that may affect product development strategies in the biosensor space.
What to do next
- Monitor for potential licensing opportunities
- Review patent claims for freedom-to-operate analysis
Archived snapshot
Apr 14, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Implantable micro-biosensor and method for operating the same
Grant US12599318B2 Kind: B2 Apr 14, 2026
Assignee
BIONIME CORPORATION
Inventors
Chun-Mu Huang, Chieh-Hsing Chen
Abstract
An implantable micro-biosensor includes a substrate, a first working electrode, at least one second working electrode, and at least one counter electrode. The first working electrode includes a first sensing section driven by a first potential difference to measure a physiological signal. The second working electrode includes a second sensing section driven by a second potential difference to consume an interfering substance. The counter electrode cooperates with the first working electrode to measure the physiological signal, cooperates with the second working electrode to consume the interfering substance, and selectively cooperates with the first or second working electrode to regenerate silver halide.
CPC Classifications
A61B 5/14503 A61B 5/1432 A61B 5/14 A61B 5/546 A61B 5/1473 A61B 5/14735 A61B 5/14865 A61B 2562/0215 A61B 2562/0223 A61B 2562/0468 A61B 2562/028 A61B 2562/125 A61B 2562/16 G01N 27/3271 G01N 27/49 G01N 27/3273
Filing Date
2020-08-03
Application No.
16983148
Claims
11
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.